• On sale!
search

HIRUDOID 40000UI * CREAM 50G

  • EG S.p.A. - Società del Gruppo STADA Arzmeimittel AG
  • 010386062

Superficial thrombophlebitis and phlebitis. Venous stasis edema. Pain, inflammation, edema, trophic disorders in post-phlebitic and varicose states. Hematomas.

info_outline View product sheet
Final Price €15.90

Volume discounts

Quantity Unit discount You Save
2 10% €3.18
5 15% €11.93
10 25% €39.75
Quantity
check_circle Available
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

EG S.p.A. - Società del Gruppo STADA Arzmeimittel AG

Discover all products

HIRUDOID 40000UI * CREAM 50G

Therapeutic indications

Superficial thrombophlebitis and phlebitis. Venous stasis edema. Pain, inflammation, edema, trophic disorders in post-phlebitic and varicose states. Hematomas.

Dosage and method of use

Pierce the membrane of the tube with the plug of the capsule. Cream: unless otherwise prescribed, place 3-5 cm of cream on the diseased part 2-3 times a day (if necessary and even more in the initial applications) and massage lightly until the cream is absorbed. In the case of particularly painful inflammations and in the presence of thrombosis, carefully spread Hirudoid 40000 IU cream on the entire affected skin area and also around it, and cover with cotton gauze or similar. In these cases the therapeutic effect of Hirudoid 40000 IU cream can be amplified by rubbing even areas further away from the part. Gel: unless otherwise prescribed, 3-5 cm of gel 2-3 times a day. Hirudoid 40000 IU gel is suitable for use in physiotherapeutic techniques such as iontophoresis and phonophoresis. In case it is used with ionophoretic technique, it must be applied on the cathode.

Contraindications

Hypersensitivity to the active substance, to a heparinoid or to any of the excipients listed in section 6.1.

Side effects

No particular undesirable effects are reported. Reporting of suspected adverse reactions : The reporting of suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Special warnings

External use; if sensitization phenomena appear, which may originate with the prolonged use of the products for skin application, the treatment must be interrupted. Hirudoid 40000 IU gel and cream contain an alcohol among the excipients and therefore should not be applied to open wounds or mucous membranes. Important information about some of the ingredients: Hirudoid 40000 IU gel. This medicine contains 5 mg of propylene glycol per g of gel.

Pregnancy and breastfeeding

There are no special precautions or warnings for the product in case of pregnancy and lactation.

Expiry and retention

Hirudoid 40000 IU gel: this medicine does not require any special storage conditions Hirudoid 40000 IU cream: store below 25 ° C.

Interactions with other drugs

No particular interactions with other medicines have been reported.

Overdose

No particular effects due to overdose are reported.

Active principles

100 g of cream contain: Active ingredient: glycosaminoglycanopolysulphate (PM 5700-13700) 445 mg equal to 40000 IU; 100 g of gel contain: Active ingredient: glycosaminoglycanopolysulphate (PM 5700-13700) mg 445 equal to 40000 IU Excipient with known effect: 0.50 g of propylene glycol (E1520). For the full list of excipients, see section 6.1.

Excipients

Cream: cutin LE, medium chain triglycerides, myristic alcohol, isopropyl myristate, bentonite, scented essence, isopropyl alcohol, imidurea, phenoxyethanol, rosemary oil. Gel: isopropanol, propylene glycol (E1520), polyacrylic acid, sodium hydroxide, purified water.

Data sheet

Packaging
cream 50 g
Product Type
HUMAN DRUG
ATC code
C05BA01
ATC description
Organic heparinoids
Therapeutic Group
Heparin
Active principle
glycosaminoglycan polysulfate
Class
C.
Pharmaceutical form
cream
Type of Administration
topical
Container
tube
Quantity
1 tube
Capacity
50 grams
Quantity of the Active Ingredient
4.45MG
Recipe required
SOP - non-prescription medicine
chat Comments (0)
Fast Order